Stock Analysis
CME Group Inc.CME
P/E 24.51×· 5Y range 18.48–37.08×· 41th percentile of history
Sector: Financial Services · Industry: Security & Commodity Brokers, Dealers, Exchanges & Services
AnalystsBuy21 analystsP/E 24.5× sits at the 41st percentile of its 5.089664613278576-year history.
Cash covers 59% of debt · Q2 2026.
PMP Verdict
High quality, fairly valued
Strengths
- Profitability82
- Growth72
Strong fundamentals at a reasonable valuation.
Bull Case
- ✓ROE 16.3% — efficient capital deployment
- ✓Interest coverage 2242.3× — debt well covered
What's happening with CME
Profile
Strong profitability and moat; valuation lags behind.
How is each axis scored?
- Valuation41/100 · Weak
- P/E vs own history (41th pct)12/25
- FCF yield (4.0%)12/25
- P/S (15.6x)5/25
- EV/EBIT (24.3x)12/25
- Growth72/100 · Moderate
- Revenue CAGR (8.6%)12/25
- Net income CAGR (11.5%)20/25
- EPS CAGR 5Y (11.4%)20/25
- Fwd implied growth (16.6%)20/25
- Profitability82/100 · Strong
- ROIC (12.4%)12/25
- ROE (16.3%)20/25
- Net margin (63.7%)25/25
- Operating margin (65.1%)25/25
- Financial Health60/100 · Moderate
- Altman Z (0.49)3/25
- Current ratio (1.02)12/25
- Interest coverage (2242.3x)25/25
- Net cash / debt (D/A 1%)20/25
- Quality63/100 · Moderate
- Piotroski F (6/9)15/25
- Beneish M (-1.77)6/25
- FCF conversion (98%)22/25
- Margin stability (σ 8.0%)20/25
- Moat75/100 · Strong
- ROIC >12% years (2/10 yrs)0/25
- Median gross margin (60.9%)25/25
- FCF-positive years (10/10 yrs)25/25
- Worst-year net margin (worst 42.7%)25/25
Risk Flags
- ⚠Altman Z 0.5 — distress-zone balance sheet
- ⚠Beneish M -1.77 — earnings-manipulation flag
About CME Group Inc.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. Show more
The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Headquarters: CHICAGO, IL · Employees: 3,875 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
41D+P/E (TTM)24.5xB
Grade B: FairPrice / TTM EPS (own statements) — vs own 5Y history: 18.5x–37.1x · 41st pct
P/FCF24.6xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield4.0%C
Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 2.5%–5.5% · 33rd pct
P/S (TTM)15.60xD
Grade D: ExpensivePrice / TTM Revenue (own statements) — vs own 5Y history: 11.7x–19.4x · 78th pct
EV/EBIT24.3xC
Grade C: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 18.2x–34.7x · 77th pct
EV/Sales8.3xC
Grade C: ExpensiveEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E21.0xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio3.98xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio3.27D
Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield3.93%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio95.1%D
Grade D: UnsustainableDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
82AROIC12.4%C
Grade C: AverageNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE16.3%C
Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks
ROA2.2%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin63.7%A
Grade A: HighNet Income / Revenue
Operating Margin65.1%A
Grade A: HighTTM EBIT / TTM Revenue
Gross Margin65.1%A
Grade A: PremiumGross Profit / Revenue
FCF Margin62.2%A
Grade A: HighFCF / Revenue
True FCF Margin60.7%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
72B+Revenue CAGR8.6%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR11.5%C
Grade C: OkCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)11.4%C
Grade C: OkCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth16.6%C
Grade C: MedAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)+0.2%B
Grade B: FlatShare count change over 5Y
SBC / Net Income2.3%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue1.5%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
60BAltman Z-Score0.49D
Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.02xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.02xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage2242.3xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment0.4yA
Grade A: FastYears to repay net debt via FCF
Net Debt/EBIT0.4xA
Grade A: LowLeverage. <2x Low, >4x High
Debt/Equity0.15xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.59xC
Grade C: PartialCash covers how much of total debt. >1 = could repay all debt from cash
Quality
63BPiotroski F-Score6/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-1.77D
Grade D: RiskyEarnings manipulation risk. < -2.22 Safe
FCF Conversion97.7%A
Grade A: StrongFCF / Net Income
Margin Stability8.0%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue1.4%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.06xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
SHEPARD WILLIAM R Filed | SHEPARD WILLIAM R | BuyOpen market buy | +293 | |
Marchese John Clifford Filed | Marchese John Clifford | Tax withholding | -44 | |
McCourt Timothy Francis Filed | McCourt Timothy Francis | Tax withholding | -364 | |
Fitzpatrick Lynne Filed | Fitzpatrick Lynne | Tax withholding | -359 | |
Sprague Suzanne Filed | Sprague Suzanne | Tax withholding | -308 |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Dennis Michael G. Filed | Dennis Michael G. | Tax withholding | -274 | |
Winkler Julie Filed | Winkler Julie | Tax withholding | -359 | |
Tobin Jack J Filed | Tobin Jack J | Tax withholding | -51 |
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
75B+ROIC >12% Years2/10 yrsD
Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)60.9%A
Grade A: DurableMedian annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years10/10 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor42.7%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$11.99
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$6.33
Cash & short-term investments per share (Finnhub)
Book Value / Share$73.82
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$3.87B
Total debt obligations (short + long term)
Cash & Equiv.$2.28B
Cash and short-term investments
Net Debt$1.59B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$26.52B
Shareholders' equity (book value)
Asset / Liability1.16xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$105.67B
Current Market Capitalization
Beta0.22B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 16, 2026
Key Insights: CME Group Inc. (CME)
CME is up 1.52% in after-hours trading. Piotroski F-Score of 6/9 indicates mixed fundamentals for CME Group Inc.. Altman Z-Score of 0.49 is below the 1.81 distress threshold — an elevated financial-risk flag. Beneish M-Score of -1.77 is above the −1.78 flag threshold, a signal that reported earnings warrant closer scrutiny.
- CME Group Inc. converts about 62% of revenue into free cash flow — strong cash generation.
- Takes ~0.4 years to repay net debt from free cash flow.
- The stock currently yields 3.9% in dividends.
See how CME ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all CME moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 5 | Regular | 269.88 | +2.56% | 2.34 |
| Oct 5 | After-hours | 270.03 | +2.62% | 2.38 |
| Sep 22 | Regular | 268.29 | -2.63% | -2.03 |
| Sep 22 | After-hours | 266.00 | -3.46% | -2.70 |
Frequently Asked Questions about CME
What is the current CME Group Inc. (CME) stock price?
CME is trading at $293.87 in after-hours trading, up 1.52% on the session. PreMarketPrice tracks CME pre-market, intraday and after-hours prices.
Is CME stock a buy right now?
PreMarketPrice's quantitative model rates CME Group Inc.'s financial health at 60/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is CME stock overvalued?
CME Group Inc. trades at a trailing P/E of 24.5 and our valuation score rates it 41/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does CME Group Inc. report earnings?
No confirmed earnings date is currently scheduled for CME. The Earnings section lists recent reports and updates as dates are announced.
What sector does CME Group Inc. operate in?
CME Group Inc. operates in the Financial Services sector, within the Security & Commodity Brokers, Dealers, Exchanges & Services industry. The Related Stocks section lists sector peers for comparison.
What does CME Group Inc. do?
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities.
About CME Group Inc. (CME) Stock
CME Group Inc. (CME) is a US-listed stock operating in the Financial Services sector, specifically the Security & Commodity Brokers, Dealers, Exchanges & Services industry. As of the latest update, CME Group Inc. is trading at $293.87, up 1.52% on the day with a market capitalization of $105.7 billion. The financial health score for CME is 60/100, which indicates good financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for CME stock.
CME Stock Analysis & Key Metrics
On PreMarketPrice, you can track CME Group Inc. (CME) across multiple dimensions:
- Pre-market price & movement: Real-time CME stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for CME with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for CME Group Inc. across multiple reporting periods.
- Financial health score: A composite score of 60/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for CME.
- Sector peers: Compare CME against 6 other financial services stocks on key financial metrics.
Is CME a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate CME Group Inc. (CME) as an investment. The financial health score of 60/100 suggests good financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.CME Group Inc. (CME) trades on NYSE. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.